CHE ▼ -3.2% - Chemed Corporation $CHE - Chemed: Vitas Healthcare Misdiagnosed Dementia Patients and 'Fudged' Evaluation Scores in Order to Admit Them into Hospice; Expert Who Reviewed Internal Documents Says They Warrant Federal Investigation -- Capitol Forum Chemed shares fell 3.2% following reports that Vitas Healthcare, a major subsidiary, allegedly misdiagnosed dementia patients and manipulated evaluation scores to admit them into hospice care. According to an expert who reviewed internal documents, the practices may warrant federal investigation. The allegations could expose the company to regulatory scrutiny, potential penalties, and reputational damage to its hospice business. 27-AUG-2026 01:06 PM ET